Posts

Flatiron Health Expands Hematology Real-World Evidence Capabilities with Launch of Six New Panoramic Datasets

Flatiron Health has announced the release of six new hematology Panoramic datasets, expanding its real-world evidence platform for blood cancer research. The datasets, which...

Why Antibodies Are Divalent: B-Cell Receptor Clustering Holds the Key to Immune Signaling

Antibodies, or immunoglobulins, have maintained a remarkably conserved structural feature throughout evolution: two identical antigen-binding sites. Although nature offers examples of highly effective monovalent...

MilliporeSigma and Promega Join Forces to Advance 3D Cell-Based Drug Discovery

MilliporeSigma, has announced a strategic partnership with Promega Corporation to co-develop new assay technologies that enable real-time monitoring of cellular activity within three-dimensional (3D)...

Machine Learning Framework Predicts the Correct Direction of Drug Target Modulation

Determining whether a drug should activate or inhibit a biological target, the direction of effect (DOE), is one of the most fundamental yet challenging...

Plasma Enolase 1 Emerges as a Promising Biomarker for Early Breast Cancer Detection

Detecting stage 1 breast cancer remains a challenge for clinicians, as small tumors often evade traditional imaging methods. Moreover, approximately 80% of detected breast...

IDT and Profluent Bio Announce Collaboration to Advance AI-Driven Enzyme Design

Integrated DNA Technologies (IDT), a Danaher company recognized for its contributions to genomics and molecular biology, has entered a research collaboration with Profluent Bio,...

Inequities in Exome Sequencing Reanalysis Across Ancestry Groups

A new study published by Ambry Genetics, examining exome sequencing outcomes across racial, ethnic, and ancestral (REA) groups reveals that disparities persist not only...

FDA Grants Breakthrough Device Designation to GeneDx Whole Genome and Exome Diagnostic Tests

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to GeneDx’s clinical whole-genome (GenomeDx) and whole-exome (ExomeDx) sequencing assays. The designation...

Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI

Thermo Fisher Scientific is deepening its investment in digital transformation with a new collaboration with OpenAI, aimed at expanding the role of artificial intelligence...

MyHeritage Transitions to Whole Genome Sequencing, Marking a Milestone in Consumer Genomics

In a recent development for the field of consumer genetics, MyHeritage, has announced the transition of its at-home DNA testing product to Whole Genome...